With so much innovation taking place in the oncology trial landscape, fueled by pharmaceutical and biotechnology companies in cancer research, it's important to know all that is going on--and what's to come in the future of oncology trials.

In the July 2024 pharmpaphorum oncology deep dive, our VP of Oncology, Ravi Karra, dives into the key trends shaping oncology clinical trials that may ultimately accelerate the path forward to new cancer treatments. 

Read the Article
Screenshot (1301)